Wolf Simon, Valerio Luca, Fumagalli Riccardo M, Konstantinides Stavros V, Ulrich Silvia, Klok Frederikus A, Cannegieter Suzanne C, Kucher Nils, Barco Stefano
Department of Angiology, University Hospital Zurich, University of Zurich, Switzerland; Department of Medicine - Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, the Netherlands.
Center for Thrombosis and Hemostasis, University Hospital of the Johannes Gutenberg University Mainz, Mainz, Germany; Department of Cardiology, University Hospital of the Johannes Gutenberg University Mainz, Mainz, Germany.
J Thromb Haemost. 2025 Apr;23(4):1340-1351. doi: 10.1016/j.jtha.2024.12.040. Epub 2025 Jan 10.
Data on the epidemiologic burden of acute pulmonary embolism (PE) in Switzerland are unavailable. Knowledge gaps remain on trends in PE-related comorbidities, PE severity, and length of in-hospital stay (LOS) at a nationwide level.
To study the epidemiology of acute PE with a focus on overall trends, sex-stratified trends, and trends in patients with (vs without) hemodynamic instability.
We used nationwide, patient-level data including all patients aged 15 years or older hospitalized for PE in Switzerland from 2003 to 2022, amounting to N = 180 600. Additionally, we analyzed the Swiss Death Registry for the same period. We estimated the disease-specific age-standardized incidence rates, mortality rates, in-hospital case fatality rates, proportional mortality rates, and LOS. Analyses were stratified by sex and the presence of features of high-risk PE.
During the study period, the PE-related incidence rate increased from 0.87 (95% CI: 0.82, 0.92) per 1000 population in 2003 to 1.19 (95% CI: 1.15, 1.24) in 2022. In contrast, a decreasing trend was found for mortality rates (18.7 [95% CI: 16.8, 20.6] per 100 000 population in 2003, 13 [95% CI: 11.7,14.2] in 2022), in-hospital case fatality rate (9.8 [95% CI: 9.1, 10.5] deaths per 100 hospitalized PE patients in 2003, 7.9 [95% CI: 7.4, 8.5] in 2019, subsequent increase during COVID-19 pandemic), and LOS (11 [Q1-Q3: 7-18] days in 2003, 8 [Q1-Q3: 4-16] in 2022). No major sex differences in trends were present. Except for LOS reduction, patients with high-risk features presented with similar trends.
The incidence of acute PE in Switzerland increased over the last 20 years. Despite increasing trends in the median age at PE diagnosis, in-hospital case fatality and mortality rates decreased, particularly among patients with high-risk features, and the LOS progressively declined.
瑞士急性肺栓塞(PE)的流行病学负担数据尚不可得。在全国范围内,关于PE相关合并症的趋势、PE严重程度和住院时间(LOS)仍存在知识空白。
研究急性PE的流行病学,重点关注总体趋势、按性别分层的趋势以及有(对比无)血流动力学不稳定患者的趋势。
我们使用了全国范围的患者层面数据,包括2003年至2022年在瑞士因PE住院的所有15岁及以上患者,共计N = 180600例。此外,我们分析了同一时期的瑞士死亡登记处数据。我们估计了特定疾病的年龄标准化发病率、死亡率、住院病死率、比例死亡率和LOS。分析按性别和高危PE特征的存在情况进行分层。
在研究期间,PE相关发病率从2003年的每1000人口0.87(95%CI:0.82,0.92)增加到2022年的1.19(95%CI:1.15,1.24)。相比之下,死亡率(2003年每10万人口18.7[95%CI:16.8,20.6],2022年为13[95%CI:11.7,14.2])、住院病死率(2003年每100例住院PE患者中有9.8[95%CI:9.1,10.5]例死亡,201年为7.9[95%CI:7.4,8.5],在COVID-19大流行期间随后增加)和LOS(2003年为11[第一四分位数 - 第三四分位数:7 - 18]天,2022年为8[第一四分位数 - 第三四分位数:4 - 16]天)呈下降趋势。趋势上没有明显的性别差异。除了LOS缩短外,具有高危特征的患者呈现出相似的趋势。
瑞士急性PE的发病率在过去20年中有所增加。尽管PE诊断时的中位年龄呈上升趋势,但住院病死率和死亡率下降,特别是在具有高危特征的患者中,并且LOS逐渐缩短。